China Jo-Jo Drugstores Announced Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
China Jo-Jo Drugstores Announced Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications Department ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement from May 3, 2023 through June 14, 2023. As set forth in Nasdaq Listing Rules 5550(a)(2) ("Nasdaq Listing Rule"), it requires that the closing bid price for the Company's ordinary shares listed on Nasdaq be maintained at a minimum of US$1.00 and failure to meet it for 30 consecutive trading days constitutes a compliance deficiency.
China Jo-Jo Drugstores, Inc.（納斯達克股票代碼：CJJD）（”Jo-Jo 藥店“或者”公司“）是中國領先的在線和線下零售商、藥品和其他醫療保健產品的批發分銷商和醫療保健提供商，今天宣佈，公司已於2023年6月15日收到納斯達克上市資格部門的通知信（”斯達克“) 通知公司，在2023年5月3日至2023年6月14日期間，它未遵守最低投標價格要求。正如納斯達克上市規則 5550 (a) (2) (”納斯達克上市規則“），它要求將公司在納斯達克上市的普通股的收盤價維持在至少1.00美元，連續30個交易日未能達到收盤價構成合規缺陷。
The notification has no immediate effect on the listing of the Company's ordinary shares on Nasdaq.
該通知對公司普通股在納斯達克的上市沒有直接影響。
譯文內容由第三人軟體翻譯。